Med-HF

Q: 如果Med-HF在你的國家或地區不可用，應該如何下載？

點擊<a href="https://apkpure.com/howto/how-to-download-an-iphone-app-if-it-is-not-available-in-your-country">此處</a>瞭解如何在受限國家或地區下載Med-HF。

Q: 運行Med-HF的最低配置要求是什麼？

以下為Med-HF的最低配置要求。<br/><ul><li>iPhone-須使用 iOS 11.0 或以上版本。</li><li>iPod touch-須使用 iOS 11.0 或以上版本。</li></ul>

免費

2.2for iPhone, iPod touch

AHS

Developer

16.1 MB

Size

2020年05月27日

Update Date

Medical

Category

12+

Age Rating

App Store 開發者網站

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Med-HF 螢幕截圖

iPhone

About Med-HF

The Med-HF App supports healthcare professionals in the initiation, titration, assessment and monitoring of 6 drug classes commonly used to treat heart failure: ACEIs/ARBs, Beta-Blockers, MRA: Mineralocorticoid Receptor Antagonist, ARNI: Angiotensin Receptor Blocker / Neprilysin Inhibitor, Ivabradine, Diuretics. This App interactively walks healthcare professionals through evidence-based algorithms, specific to these 6 drug classes, and recommends appropriate actions and considerations based on 2018 Canadian Cardiovascular Society Heart Failure Guidelines.

Features:
• Recommendations for medication initiation, titration, assessment and monitoring
• Dosing information
• References
• Clinical pearls
• General approach and drug class algorithms